Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Help me understand - To 300

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Mar 31, 2011 5:24pm

191 Views

Post# 18369803

RE: Help me understand - To 300

The news isn`t even on the Stockhouse site a day later. Halo really needs to do something about its poor following . These are very good precious metal results on their own without the rest of the project . Having HudBay on board can actually be a disagvantage if investors don`t know the whole story. Halo really needs to do something about getting some big time analysts involved in this story. There is no point preaching to the choir and hopeing for the best. Promoting a company is a business in itself.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Jan. 10, 2025)